WALTHAM, Mass., July 18, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its second quarter 2024 financial results on Thursday, August 1, 2024, at 8:30 a.m. ET.
To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across serious retinal, rare, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.
Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178
PUNE, India, July 19, 2024 /PRNewswire/ -- Wearable Technology Market size is expected to grow…
PUNE, India, July 19, 2024 /PRNewswire/ -- Printed & Flexible Sensors Market size was valued…
Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from…
Company Now Servicing Over 9 Million Veterans NEW YORK, July 19, 2024 /PRNewswire/ -- Legacy,…
CHICAGO, IL / ACCESSWIRE / July 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or…
AUSTIN, TX / ACCESSWIRE / July 19, 2024 / Medicare officially announces LCD changes that…